AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost efficiency, giving laboratories of all sizes the freedom to customize their workflows and explore a wider array of applications. Powered by innovative SBX technology, the platform is capable of end-to-end, same-day, whole-genome sequencing in research workflows, with accurate results within hours. The AXELIOS [...]

Genovis AB today announces the commercial launch of AlligBAITOR™, a novel immunoglobulin-binding protein that expands the company's offering in advanced protein analysis. The product enables capture of all major antibody isotypes and uniquely facilitates the release of antigens from antibody-antigen complexes under native conditions. Together with the high-performance enzymes added through the recent acquisition of [...]

Accelerating Entry into the Middle East Energy Transition Market HORIBA, Ltd. (President: Masayuki Adachi; hereinafter “HORIBA”) announced on February 13, 2026, the establishment of HORIBA Middle East Limited in Abu Dhabi. The new company marks HORIBA’s first presence in the Middle East and will be located in Masdar City,  a pioneering sustainable urban community and [...]

Highly complementary combination expands Agilent’s pathology portfolio and ability to serve customers across clinical and research settings Expected to be accretive to Agilent’s top-line growth rate, margin profile and non-instrument revenue mix in the first year SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition [...]

Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion). Darmstadt, Germany Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) Proposed acquisition expected to be immediately accretive to sales growth and EBITDA pre margin post-closing, and EPS [...]

From Europe Biobank Week 2026 in Prague to Interphex Week Tokyo 2026, Haier Biomedical continuously strengthens global life sciences market presence through localized innovative products and profound ecosystem partnerships QINGDAO, China -- Haier Biomedical (688139.SH), a global leader in life sciences and medical solutions, is making simultaneous presence at Europe Biobank Week 2026 in Prague, one [...]

Joint offering creates state-of-the-art workflow uniting Promega's fast and reliable nucleic acid extraction instrumentation with Countable Labs' accurate and easy-to-use Countable PCR technology to deliver accuracy across research PALO ALTO, Calif. & MADISON, Wis. -- Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, announced a co-marketing agreement [...]

Industry veteran will strengthen BioIVT's scientific strategy by advancing the quality, characterization, and applicability of biospecimens to meet emerging research needs WOODBURY, NY – BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it has appointed Sean Downing, PhD, to its Scientific Advisory Board to continue advancing the [...]

IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. Waters Biosciences' technologies, including BD FACSDiscover™ and BD Rhapsody™ Instruments, will be used with IMU's AI analytics in research to deliver deeper, population-level disease insights. Partnership supports IMU's expansion of [...]

Männedorf, Switzerland -- Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging NVIDIA BioNeMo Agent Toolkit. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to [...]